Drug Profile
Research programme: therapeutic vaccines - Immunovo
Alternative Names: Anti-PD-L1 vaccine - Immunovo; Anti-sclerostin vaccine - ImmunovoLatest Information Update: 28 May 2019
Price :
$50
*
At a glance
- Originator Immunovo
- Class Vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Bone disorders; Cancer
Most Recent Events
- 28 May 2019 No recent reports of development identified for research development in Bone-disorders in Netherlands
- 28 May 2019 No recent reports of development identified for research development in Cancer in Netherlands
- 06 Apr 2015 Early research in Bone disorders in Netherlands (unspecified route)